Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma

This study was funded by the Academician Workstation of Jun Ma (YSGZZ2024001), the Specific Research Fund of the Innovation Platform for Academicians of Hainan Province (YSPTZX202501), the National Natural Science Foundation of China (82573549, 82172870), the Guangdong Special Support Program for Young Top Talents (TZ09B0046), and the Guangzhou Science and Technology Program (2023A04J1786).

Authors

Institutions

Publication Details

Journal
Med
Published
2026-02-13
DOI
https://doi.org/10.1016/j.medj.2025.100994
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma

Min-Yu Wen, Ying-Ni Zhang, Ying-Qin Li, Yuzhe Wang et al.
Med
Head and Neck Cancer Studies
article

Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma

Min-Yu Wen, Ying-Ni Zhang, Ying-Qin Li, Yuzhe Wang, Shu-Bin Hong, Ji-Bin Li, Yuan Zhang, Kun-Yu Yang, Xu Liu, Guan-Qun Zhou, Xiao-Zhong Chen, Feng Jin, Kai-Bin Yang, Jia-Xi Shen, Ai-Hua Lin, Ying Sun, Wen-Fei Li, Hong-Yun Zhao, De-Sheng Hu, Cheng Xu, Ze-Qi Lin, Shao-Jun Lin, Liang-Fang Shen, Jun Ma, Hui-Ling Huang, Ling-Long Tang
article en

Abstract

This study was funded by the Academician Workstation of Jun Ma (YSGZZ2024001), the Specific Research Fund of the Innovation Platform for Academicians of Hainan Province (YSPTZX202501), the National Natural Science Foundation of China (82573549, 82172870), the Guangdong Special Support Program for Young Top Talents (TZ09B0046), and the Guangzhou Science and Technology Program (2023A04J1786).

MedVol. 7(3)
Fujian Medical University (CN), Central South University (CN), Guiyang Medical University (CN), Sun Yat-sen University (CN), Zhejiang Cancer Hospital (CN), Affiliated Hospital of Guizhou Medical University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Wuhan Union Hospital (CN), Sun Yat-sen University Cancer Center (CN), Fujian Provincial Cancer Hospital (CN), Xiangya Hospital Central South University (CN), Hubei Cancer Hospital (CN), Union Hospital (CN), Huazhong University of Science and Technology (CN)
Industry, innovation and infrastructure
Openalex Percentile: Top 56%
Head and Neck Cancer Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma — Min-Yu Wen, Ying-Ni Zhang, et al. · Med (2026) | TGRS Research Map | TGRS